See also this year's filing and all EDGAR filings for this company.
PDF Report 0001589150_2017_Regen_BioPharma_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001589150')"} |
Graph
Absolute values for 0001589150, Regen BioPharma Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 207,356 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 112,000 |
| 4 | LiabilitiesCurrent | 799,201 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 107,057 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,664,250 |
| 9 | ResearchAndDevelopmentExpense | 671,095 |
| 10 | remainder_Expenses | 721,617 |
| 11 | remainder_Revenues | 100,000 |
| 12 | remainder_NetIncome | -4,793,633 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 319,356 |
| 1 | Liabilities | 906,258 |
| 2 | Expenses | 3,056,962 |
| 3 | Revenues | 100,000 |
| 4 | StockholdersEquity | -586,902 |
| 5 | NetIncome | -7,750,595 |
| 6 | ComprehensiveNetIncome | -7,750,595 |
| 7 | BaseVar | 4,588,104 |
| 8 | EconomicCapitalRatio | -14.3 |
Edgar->Model Mapping
Feature Distribution
